Skip to content

Myriad Genetics MYGN Interest coverage

Interest coverage at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
6.4×+1.4×
NeoGenomics logo
NeoGenomicsNEO
-38.9×-84.6×
Guardant Health logo
Guardant HealthGH
-100.5×-28.6×
Natera, Inc. logo
Natera, Inc.NTRA
-81.9×-157×
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-1,358×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-4×-1.6×

Other financials

Income statement

See full
Revenue$200.4M+2.3%
Gross profit$137.6M+2.5%
Operating income-$30.7M-5.9%
Net income-$34.1M-34,000%
EPS (diluted)-$0.36

Balance sheet

See full
Cash & equivalents$126.0M+24.8%
Total debt$211.5M+34.2%
Total equity$337.4M-52.1%
Total assets$673.7M-33.0%

Cash flow

See full
Operating cash flow-$15.7M+3.7%
CapEx$18.8M+181%
Free cash flow-$19.7M+65.1%

Valuation

See full
Market cap$512.85M+13.1%
Enterprise value$598.35M+17.3%
P/S0.6×+0.1×

Profitability

See full
Gross margin70%0.0pp
Operating margin-46.9%-88.3pp
Net margin-48.2%-72.9pp
FCF margin-17%

Returns & leverage

See full
Return on equity-76.7%-98.4pp
Debt / equity0.6×+0.4×
Current ratio2.4×+0.5×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

Based on trailing twelve months.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Myriad Genetics's interest coverage?
Myriad Genetics (MYGN) reported interest coverage of -28.2× in Q1 2026.
How has Myriad Genetics's interest coverage changed year-over-year?
Myriad Genetics's interest coverage increased by 29.8% year-over-year, from -40.2× to -28.2×.
What is the long-term trend for Myriad Genetics's interest coverage?
Over 5 years (2020 to 2025), Myriad Genetics's interest coverage has grown at a 10.5% compound annual growth rate (CAGR), from -22.4× to -36.9×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.